| dc.contributor.author |
Evdokimov N.M. |
|
| dc.contributor.author |
Lamoral-Theys D. |
|
| dc.contributor.author |
Mathieu V. |
|
| dc.contributor.author |
Andolfi A. |
|
| dc.contributor.author |
Frolova L.V. |
|
| dc.contributor.author |
Pelly S.C. |
|
| dc.contributor.author |
Van Otterlo W.A.L. |
|
| dc.contributor.author |
Magedov I.V. |
|
| dc.contributor.author |
Kiss R. |
|
| dc.contributor.author |
Evidente A. |
|
| dc.contributor.author |
Kornienko A. |
|
| dc.date.accessioned |
2012-01-18T08:06:28Z |
|
| dc.date.available |
2012-01-18T08:06:28Z |
|
| dc.date.issued |
2011 |
|
| dc.identifier.citation |
Bioorganic and Medicinal Chemistry |
|
| dc.identifier.citation |
19 |
|
| dc.identifier.citation |
23 |
|
| dc.identifier.citation |
http://www.scopus.com/inward/record.url?eid=2-s2.0-80655146928&partnerID=40&md5=387132308634a89e1234ac70dffd5f10 |
|
| dc.identifier.issn |
9680896 |
|
| dc.identifier.other |
10.1016/j.bmc.2011.09.051 |
|
| dc.identifier.uri |
http://hdl.handle.net/10019.1/18999 |
|
| dc.description |
Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za |
|
| dc.subject |
1 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl benzoate |
|
| dc.subject |
1 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl pivalate |
|
| dc.subject |
1 hydroxy 4,5,7,12b tetrahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 2(3a1h) one |
|
| dc.subject |
1,2 dihydroxy 3a1,4,5,12b tetrahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(2h) one |
|
| dc.subject |
1,2,3 trihydroxy 2,3,5,12b tetrahydroxy1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(3a1h) one |
|
| dc.subject |
1,2,3,4 tetrahydroxy 3,3a,3a1,4,5,12b hexahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(2h) one |
|
| dc.subject |
2 (triisopropylsilyloxy) 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 ol |
|
| dc.subject |
2 (triisopropylsilyloxy)2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl acetate |
|
| dc.subject |
2 (triisopropylsilyloxy)2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl palmitate |
|
| dc.subject |
2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl acetate |
|
| dc.subject |
2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl benzoate |
|
| dc.subject |
2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl palmitate |
|
| dc.subject |
2 hydroxy 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 1 yl stearate |
|
| dc.subject |
2 hydroxy 4h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 7(5h) one |
|
| dc.subject |
2,3a,4,5,7,12b hexahydro 1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate |
|
| dc.subject |
2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl dibenzoate |
|
| dc.subject |
3,3a dihydroxy 7 oxo 2,3,3a,3a,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate |
|
| dc.subject |
3a hydroxy 7 oxo 2,3,3a,3a1,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,triyl triacetate |
|
| dc.subject |
7 oxo 2,3,3a1,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,triyl triacetate |
|
| dc.subject |
7 oxo 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate |
|
| dc.subject |
7 oxo 5,7 dihydro 4h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridin 2 yl acetate |
|
| dc.subject |
7 thioxo 2,3,3a,3a1,4,5,7,12b octahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2,3,3a tetraol |
|
| dc.subject |
7 thioxo 2,3a1,4,5,7,12b hexahydro1h [1,3]dioxolo[4,5 j]pyrrolo[3,2,1 de]phenanthridine 1,2 diyl diacetate |
|
| dc.subject |
alkene |
|
| dc.subject |
cytostatic agent |
|
| dc.subject |
hydroxyl group |
|
| dc.subject |
long chain fatty acid |
|
| dc.subject |
lycorine |
|
| dc.subject |
paclitaxel |
|
| dc.subject |
unclassified drug |
|
| dc.subject |
unindexed drug |
|
| dc.subject |
antineoplastic activity |
|
| dc.subject |
apoptosis |
|
| dc.subject |
article |
|
| dc.subject |
cancer inhibition |
|
| dc.subject |
controlled study |
|
| dc.subject |
derivatization |
|
| dc.subject |
dihydroxylation |
|
| dc.subject |
drug structure |
|
| dc.subject |
drug synthesis |
|
| dc.subject |
glioblastoma |
|
| dc.subject |
human |
|
| dc.subject |
in vitro study |
|
| dc.subject |
lung non small cell cancer |
|
| dc.subject |
melanoma |
|
| dc.subject |
nonhuman |
|
| dc.subject |
solid tumor |
|
| dc.subject |
structure activity relation |
|
| dc.subject |
tumor cell line |
|
| dc.subject |
Amaryllidaceae |
|
| dc.title |
In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives |
|
| dc.type |
Article |
|